University of Texas's MD Anderson, Empyrean Announce Agreement to Develop Novel Radiation Therapy Technologies
August 11, 2022
August 11, 2022
HOUSTON, Texas, Aug. 11 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
The University of Texas MD Anderson Cancer Center and Empyrean Medical Systems, Inc. today announced an exclusive license and joint development agreement to advance novel technologies and products in the fields of radiation oncology and cancer therapeutics.
This agreement brings together the complementary research and development expertise of b . . .
The University of Texas MD Anderson Cancer Center and Empyrean Medical Systems, Inc. today announced an exclusive license and joint development agreement to advance novel technologies and products in the fields of radiation oncology and cancer therapeutics.
This agreement brings together the complementary research and development expertise of b . . .